Episode Summary
Executive Summary: Tim Ferriss interviews Dr. Dominic D’Agostino about ketosis, fasting, exogenous ketones, and metabolic therapies for performance and disease. The conversation spans strength training, seizure control, cancer metabolism, mitochondrial function, and practical keto eating, with Dom arguing that ketones can improve resilience, preserve muscle, and potentially augment treatments for cancer and neuroinflammation.
Main Topics: Ketosis and fasting as metabolic states (Priority: 5/5): Dom explains how fasting depletes glycogen, lowers insulin, and raises ketones, which can fuel the brain and shift the body into a protective, fat-based metabolic state. Performance, strength, and body composition on keto (Priority: 5/5): They discuss Dom’s own fasting/deadlifting feats and a study in advanced lifters showing ketogenic diets can maintain or improve strength, hypertrophy, and fat loss. Exogenous ketones and ketone esters (Priority: 5/5): The episode explores ketone salts, ketone esters, and MCTs as tools to raise blood ketones quickly, reduce transition stress, and potentially mimic some fasting benefits. Cancer metabolism and therapeutic ketosis (Priority: 5/5): Dom argues that ketogenic diets, fasting, metformin, DCA, and possibly BCAAs may help starve tumors, preserve lean mass, and improve outcomes when combined with standard care. Neuroprotection, inflammation, and disease prevention (Priority: 4/5): The discussion covers ketones’ anti-inflammatory effects, HDAC inhibition, mitochondrial efficiency, and possible relevance to Alzheimer’s, Parkinson’s, Lyme disease, and seizure disorders. Practical keto lifestyle and supplementation (Priority: 3/5): Dom shares his daily eating pattern, supplement stack, travel strategy, and how he uses MCTs, ketone products, BCAAs, coffee, and high-fat meals to stay in ketosis. Research methods, IRBs, and translational science (Priority: 3/5): They touch on animal/human study design, IRB/IACUC hurdles, sample size, statistical power, and the challenge of funding nutrition and metabolic research.
Key Arguments: Ketosis is a natural fasting-adapted state that can be induced by diet, fasting, or exogenous ketones and may improve brain fuel stability and resilience. Ketones are anti-catabolic and can spare muscle by reducing the need to break down amino acids for glucose during energy deficit. A ketogenic diet can support strength and hypertrophy in advanced lifters while improving body composition, especially when protein intake is adequate. Exogenous ketones can rapidly raise blood ketones and may ease the transition into ketosis, reducing symptoms like irritability, brain fog, and stress. Ketones have broader signaling roles beyond fuel, including HDAC inhibition and anti-inflammatory effects that may matter for aging and chronic disease. For cancer, Dom argues that lowering glucose/insulin availability while supporting healthy tissue with ketosis, fasting, metformin, DCA, and possibly BCAAs could improve outcomes. Cancer cells often have defective mitochondria and limited ketolytic capacity, making ketones a poor fuel for tumors but a useful fuel for healthy cells. Fasting before chemotherapy may sensitize tumors and protect healthy tissue, though it should be individualized and medically supervised. Metformin may mimic some calorie-restriction/fasting effects and showed survival benefits in Dom’s metastatic cancer model. Ketogenic diets may help with neuroinflammation and mitochondrial dysfunction, which could explain benefits seen in Lyme disease and some neurological conditions.
Data Points: Fast duration: 7 days - Dom fasted for a week before deadlifting and discussing ketosis research. Deadlift after fasting: 500 lb for 10 reps; 585 lb for 1 rep - Dom’s personal example of strength maintained after prolonged fasting. Blood glucose during fast: mid-30s to low-40s mg/dL - Dom reported his glucose during the 7-day fast. Blood ketones during fast: about 5 mmol/L - Dom’s ketone level during the fast. Ketosis threshold: ~0.5 mmol/L - Clinical definition of nutritional ketosis mentioned in the discussion. Typical health/longevity ketosis target: 1–3 mmol/L - Dom’s preferred range for general health and performance. Higher ketosis range: 5–6 mmol/L - Dom noted this can create mild metabolic acidosis and greater physiological load. Advanced lifter study sample: 12 subjects - Ketogenic diet study in advanced resistance-trained individuals. Diet composition in lifter study: 75–80% fat; 20–25 g carbs/day - Ketogenic arm of the resistance-training study. Protein in lifter study: ~25% protein - Higher protein than classical ketogenic diets, intended to support growth and repair. Ketone ester rat study: 4–5 mmol/L within 15–30 minutes - Rats on standard chow reached starvation-level ketosis rapidly after a ketone ester dose. Oxygen toxicity resistance: 575% average increase - Rats given ketone ester resisted oxygen toxicity far longer than controls. Breath-hold improvement: ~3.5–4 minutes - Tim reported a fasting breath-hold time more than double his usual. Ketone transporter adaptation: ~50% increase in transporter subunits after 4 weeks - Rodent data on upregulation of monocarboxylate transporters with ketogenic adaptation. Metformin self-experiment: 1–2 g/day for ~12 weeks - Dom described his own metformin trial and side effects/tolerance. Metformin effect on lipids: HDL rose to 98; triglycerides lowest ever - Dom’s personal bloodwork while taking metformin. Metformin effect on testosterone: lowered testosterone - Dom observed reduced testosterone during metformin use, later returning to normal after stopping. Metformin cancer model survival: ~40–50% increase - Metformin extended survival in Dom’s metastatic cancer animal model. BCAA + ketogenic diet survival: ~50% increase in survival with keto alone; trend with added BCAAs - Animal study in advanced metastatic cancer. DCA dose range discussed: 10–50 mg/kg - Dom described a cautious dosing range before neuropathy risk rises. DCA neuropathy threshold: ~50 mg/kg - Higher doses associated with peripheral neuropathy symptoms. Ketone supplement toxicology study: 25 g/kg/day for 15 weeks in rats - High-dose safety testing of ketone supplements showed no major toxicity signals. Ketone supplement servings: up to 3 servings/day on label - Dom discussed product guidance and GI tolerance limits.
Pivotal Quotes: "I just say I'm a scientist and I study nutritional neuroscience." — Dr. Dominic D'Agostino: His concise answer to what he does professionally. "Ketones are anti-catabolic protein-sparing effect." — Dr. Dominic D'Agostino: Explaining why ketosis can preserve muscle during fasting or calorie deficit. "I think the ketogenic diet would be absolutely like your base therapy, right?" — Dr. Dominic D'Agostino: His view on a metabolic strategy for aggressive cancer, alongside fasting and adjuncts.
Implications: The episode frames ketosis as more than a diet: a metabolic tool with potential uses in performance, neuroprotection, and oncology. For listeners, it suggests practical experimentation may help, but serious disease applications require medical supervision and better trials.
About The Tim Ferriss Show
Tim Ferriss is a self-experimenter and bestselling author, best known for The 4-Hour Workweek. In this show, he deconstructs world-class performers from eclectic areas (investing, sports, business, art, etc.) to extract the tactics, tools, and routines you can use.